BASELINE BIOMARKERS PREDICT BETTER RESPONSES TO DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2 TRIAL IN PSORIATIC ARTHRITIS

被引：2

作者：

Fitzgerald, O. ^{[1
]}

Gladman, D. D. ^{[2
]}

Mease, P. J. ^{[3
,4
]}

Ritchlin, C. T. ^{[5
]}

Smolen, J. S. ^{[6
]}

Gao, L. ^{[7
]}

Hu, S. ^{[8
]}

Nowak, M. ^{[9
]}

Banerjee, S. ^{[10
]}

Catlett, I. ^{[11
]}

机构：

[1] Univ Coll Dublin UCD, Conway Inst, Rheumatol, Dublin, Ireland

[2] Univ Toronto, Rheumatol, Toronto, ON, Canada

[3] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[4] Univ Washington, Rheumatol Res, Seattle, WA 98195 USA

[5] Univ Rochester, Med Ctr, Allergy Immunol & Rheumatol, Rochester, NY 14627 USA

[6] Med Univ Vienna, Rheumatol, Vienna, Austria

[7] Bristol Myers Squibb, Immunosci & Small Mol, Princeton, NJ USA

[8] Bristol Myers Squibb, Bioinformat, Princeton, NJ USA

[9] Bristol Myers Squibb, Clin R&D, Princeton, NJ USA

[10] Bristol Myers Squibb, Rheumatol & Dermatol, Princeton, NJ USA

[11] Bristol Myers Squibb, Dermatol, Princeton, NJ USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2468

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0005

引用

页码：215 / 216

页数：2

共 3 条

[1]

FitzGerald O, 2021, 2021 ACR CONV AM COL

[2] International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting [J].

Kohn, Alison H. ;

Alavi, Afsaneh ;

Armstrong, April W. ;

Babalola, Folawiyo ;

Garg, Amit ;

Gottlieb, Alice B. ;

Grilli, Lesley ;

Jemec, Gregor Borut Ernst ;

Latella, John ;

Marcus, Kendall ;

Merola, Joseph F. ;

Ortega-Loayza, Alex G. ;

Siegel, Daniel M. ;

Strand, Vibeke ;

Tan, Jerry K. L. ;

Perez-Chada, Lourdes M. .

DERMATOLOGY, 2022, 238 (03) :430-437

[3]

Mease PJ., Ann Rheum Dis

← 1 →